Background: During the last decades, a large number of phenotypes and disease classifications of allergic diseases have been proposed. Despite the heterogeneity across studies, no systematic review has been conducted on phenotype classification and the criteria that define allergic diseases. We aimed to identify clinically expressed, population-based phenotypes of allergic diseases and their interrelationships, to explore disease heterogeneity and to evaluate the measurements employed in disease diagnosis. Methods: We conducted a search of MEDLINE up to December 2012, to identify relevant original studies published in the English language that examine at least one objective of this systematic review in subjects aged 0-18 years. The screening of titles and abstracts and the extraction of data were conducted independently by two reviewers. Results: From a total of 13,767 citations, 197 studies met the criteria for inclusion, with 54% being cohort studies. Allergic diseases were studied as a single entity in 55% (109/197) of the studies or in the context of multimorbidity in 45%. Asthma accounted for 81.7% of the studies examining single diseases. Overall, up to 33 different phenotypes of allergic disease were reported. Transient early, late-onset and persistent wheeze were the most frequently reported phenotypes. Most studies (78%) used questionnaires. The skin-prick test was the preferred measurement of sensitization (64%). Spirometry and bronchial hyperresponsiveness were assessed in one third of the studies, peak flow rate in 8.6% and disease severity in 35%. Conclusions: Studies reporting phenotypes of allergic diseases in children are highly heterogeneous and often lack objective phenotypical measures. A concerted effort to standardize methods and terminology is necessary.

Keywords:
Phenotype, Disease definition, Asthma, Urticaria, Allergy, Eczema, Rhinitis, Anaphylaxis
1.
Pawankar R, Canonica GW, Holgate ST, Lockey RF, Blaiss M: The WAO White Book on Allergy, updated 2013.
2.
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al: Allergic Rhinitis and Its Impact on Asthma (ARIA), 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(suppl 86):8-160.
3.
Bousquet J, Khaltaev N: Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach. Global Alliance against Chronic Respiratory Diseases, World Health Organization, 2007.
4.
Bieber T: Atopic dermatitis. N Engl J Med 2008;358:1483-1494.
5.
Simon H-U, Rothenberg ME, Bochner BS, Weller PF, Wardlaw AJ, Wechsler ME, et al: Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 2010;126:45-49.
6.
Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832-836.
7.
Bousquet J, Fokkens W, Burney P, Durham SR, Bachert C, Akdis CA, et al: Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy 2008;63:842-853.
8.
Bousquet J, Anto JM, Bachert C, Bousquet PJ, Colombo P, Crameri R, et al: Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy 2006;61:671-680.
9.
Bel EH: Clinical phenotypes of asthma. Curr Opin Pulm Med 2004;10:44-50.
10.
Wenzel SE: Asthma: defining of the persistent adult phenotypes. Lancet 2006;368:804-813.
11.
Ballardini N, Kull I, Lind T, Hallner E, Almqvist C, Ostblom E, et al: Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohort. Allergy 2012;67:537-544.
12.
Pinart M, Benet M, Annesi-Maesano I, von Berg A, Berdel D, Carlsen KCL, et al: Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir Med 2014;2:131-140.
13.
Spergel JM, Paller AS: Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003;112:S118-S127.
14.
Van Wonderen KE, Van Der Mark LB, Mohrs J, Bindels PJE, Van Aalderen WMC, Ter Riet G: Different definitions in childhood asthma: how dependable is the dependent variable? Eur Respir J 2010;36:48-56.
15.
Bousquet J, Anto J, Auffray C, Akdis M, Cambon-Thomsen A, Keil T, et al: MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy 2011;66:596-604.
16.
Pinart M, Garcia-Aymerich J, Gimeno-Santos E, Benet M, Guerra S, Antó MJ, et al: A systematic review to define classical IgE-associated diseases from birth to adolescence: the MeDALL study. http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42012002443.
17.
Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
18.
Pinart M, Maier D, Gimeno-Santos E, Sola I, Garcia-Aymerich J, Guerra S, et al: Systematic review protocol to define classical IgE-associated diseases from birth to adolescence: the MeDALL Study. WebmedCentral ALLERGY 2012;3:WMC003408.
19.
Maier D, Kalus W, Wolff M, Kalko SG, Roca J, Marin de Mas I, et al: Knowledge management for systems biology a general and visually driven framework applied to translational medicine. BMC Syst Biol 2011;5:38.
20.
Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ: Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133-138.
21.
Wilson NM, Bridge P, Silverman M: Bronchial responsiveness and symptoms in 5-6 year old children: a comparison of a direct and indirect challenge. Thorax 1995;50:339-345.
22.
Brussee JE, Smit HA, Koopman LP, Wijga AH, Kerkhof M, Corver K, et al: Interrupter resistance and wheezing phenotypes at 4 years of age. Am J Respir Crit Care Med 2004;169:209-213.
23.
McKenzie SA, Bridge PD, Healy MJ: Airway resistance and atopy in preschool children with wheeze and cough. Eur Respir J 2000;15:833-838.
24.
Lodrup Carlsen KC, Carlsen KH, Nafstad P, Bakketeig L: Perinatal risk factors for recurrent wheeze in early life. Pediatr Allergy Immunol 1999;10:89-95.
25.
Oh M-A, Shim JY, Jung Y-H, Seo J-H, Young Kim H, Kwon J-W, et al: Fraction of exhaled nitric oxide and wheezing phenotypes in preschool children. Pediatr Pulmonol 2013;48:563-570.
26.
Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F: Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006;354:1998-2005.
27.
Sonnappa S, Bastardo CM, Wade A, Saglani S, McKenzie SA, Bush A, et al: Symptom-pattern phenotype and pulmonary function in preschool wheezers. J Allergy Clin Immunol 2010;126:519-526.e7.
28.
Belgrave DCM, Granell R, Simpson A, Guiver J, Bishop C, Buchan I, et al: Developmental profiles of eczema, wheeze, and rhinitis: two population-based birth cohort studies. PLoS Med 2014;11:e1001748.
29.
Belgrave DCM, Buchan I, Bishop C, Lowe L, Simpson A, Custovic A: Trajectories of lung function during childhood. Am J Respir Crit Care Med 2014;189:1101-1110.
30.
Cerecedo I, Zamora J, Fox M, Voordouw J, Plana N, Rokicka E, et al: The impact of double-blind placebo-controlled food challenge (DBPCFC) on the socioeconomic cost of food allergy in Europe. J Investig Allergol Clin Immunol 2014;24:418-424.
31.
Datema M, Zuidmeer-Jongejan L, Asero R, Barreales L, de Blay F, Bures P, et al: Hazelnut allergy across Europe dissected molecularly: a EuroPrevall outpatient clinic survey. J Allergy Clin Immunol 2015;136:382-391.
32.
Schoemaker A, Sprikkelman A, Grimshaw K, Roberts G, Grabenhenrich L, Rosenfeld R, et al: Incidence and natural history of challenge-proven cow's milk allergy in European children - EuroPrevall birth cohort. Allergy 2015;70:963-972.
33.
Montoro J, Del Cuvillo A, Mullol J, Molina X, Bartra J, Dávila I, et al: Validation of the modified allergic rhinitis and its impact on asthma (ARIA) severity classification in allergic rhinitis children: the PEDRIAL study. Allergy 2012;67:1437-1442.
34.
Jáuregui I, Dávila I, Sastre J, Bartra J, del Cuvillo A, Ferrer M, et al: Validation of ARIA (Allergic Rhinitis and Its Impact on Asthma) classification in a pediatric population: the PEDRIAL study. Pediatr Allergy Immunol 2011;22:388-392.
35.
Lang A, Mowinckel P, Sachs-Olsen C, Riiser A, Lunde J, Carlsen K-H, et al: Asthma severity in childhood, untangling clinical phenotypes. Pediatr Allergy Immunol 2010;21:945-953.
36.
Schmitt J, Williams H; HOME Development Group: Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany. Br J Dermatol 2010;163:1166-1168.
37.
Chawes BLK, Bønnelykke K, Kreiner-Møller E, Bisgaard H: Children with allergic and nonallergic rhinitis have a similar risk of asthma. J Allergy Clin Immunol 2010;126:567-573.e1-e8.
38.
Schnabel E, Sausenthaler S, Schaaf B, Schäfer T, Lehmann I, Behrendt H, et al: Prospective association between food sensitization and food allergy: results of the LISA birth cohort study. Clin Exp Allergy 2010;40:450-457.
39.
Ostblom E, Lilja G, Pershagen G, van Hage M, Wickman M: Phenotypes of food hypersensitivity and development of allergic diseases during the first 8 years of life. Clin Exp Allergy 2008;38:1325-1332.
40.
Baehler P, Chad Z, Gurbindo C, Bonin AP, Bouthillier L, Seidman EG: Distinct patterns of cow's milk allergy in infancy defined by prolonged, two-stage double-blind, placebo-controlled food challenges. Clin Exp Allergy 1996;26:254-261.
41.
Warrier PJ, Bellamkonda P, Stokes JR, Casale TB: Utility and limitations of objective measures of asthma. Ann Allergy Asthma Immunol 2009;102:518-522.
42.
Young S, Arnott J, O'Keeffe PT, Le Souef PN, Landau LI: The association between early life lung function and wheezing during the first 2 years of life. Eur Respir J 2000;15:151-157.
43.
Palmer LJ, Rye PJ, Gibson NA, Burton PR, Landau LI, Lesouëf PN: Airway responsiveness in early infancy predicts asthma, lung function, and respiratory symptoms by school age. Am J Respir Crit Care Med 2001;163:37-42.
44.
Lowe LA, Simpson A, Woodcock A, Morris J, Murray CS, Custovic A: Wheeze phenotypes and lung function in preschool children. Am J Respir Crit Care Med 2005;171:231-237.
45.
Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43:343-373.
46.
Westman M, Lupinek C, Bousquet J, Andersson N, Pahr S, Baar A, et al: Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence. J Allergy Clin Immunol 2015;135:1199-1206.
47.
Bousquet J, Anto JM, Demoly P, Schünemann HJ, Togias A, Akdis M, et al: Severe chronic allergic (and related) diseases: a uniform approach - a MeDALL-GA2LEN-ARIA position paper. Int Arch Allergy Immunol 2012;158:216-231.
48.
Schultz A, Devadason S, Savenije O, Sly P, Le Souëf P, Brand P: The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheeze. Acta Paediatr 2010;99:56-60.
49.
Bertelsen RJ, Carlsen KCL, Carlsen K-H: Rhinitis in children: co-morbidities and phenotypes. Pediatr Allergy Immunol 2010;21:612-622.
50.
Kuyucu S, Saraçlar Y, Tuncer A, Geyik PO, Adalioğlu G, Akpinarli A, et al: Epidemiologic characteristics of rhinitis in Turkish children: the International Study of Asthma and Allergies in Childhood (ISAAC) phase 2. Pediatr Allergy Immunol 2006;17:269-277.
51.
Marinho S, Simpson A, Lowe L, Kissen P, Murray C, Custovic A: Rhinoconjunctivitis in 5-year-old children: a population-based birth cohort study. Allergy 2007;62:385-393.
52.
Kulig M, Klettke U, Wahn V, Forster J, Bauer CP, Wahn U: Development of seasonal allergic rhinitis during the first 7 years of life. J Allergy Clin Immunol 2000;106:832-839.
53.
Laan MP, Baert MR, Bijl AM, Vredendaal AE, De Waard-van der Spek FB, Oranje AP, et al: Markers for early sensitization and inflammation in relation to clinical manifestations of atopic disease up to 2 years of age in 133 high-risk children. Clin Exp Allergy 2000;30:944-953.
54.
Keil T, Bockelbrink A, Reich A, Hoffmann U, Kamin W, Forster J, et al: The natural history of allergic rhinitis in childhood. Pediatr Allergy Immunol 2010;21:962-969.
55.
Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al: A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-824.
56.
Wickman M, Ahlstedt S, Lilja G, van Hage Hamsten M: Quantification of IgE antibodies simplifies the classification of allergic diseases in 4-year-old children. A report from the prospective birth cohort study - BAMSE. Pediatr Allergy Immunol 2003;14:441-447.
57.
Mortureux P, Léauté-Labrèze C, Legrain-Lifermann V, Lamireau T, Sarlangue J, Taïeb A: Acute urticaria in infancy and early childhood: a prospective study. Arch Dermatol 1998;134:319-323.
58.
Chang K-L, Yang Y-H, Yu H-H, Lee J-H, Wang L-C, Chiang B-L: Analysis of serum total IgE, specific IgE and eosinophils in children with acute and chronic urticaria. J Microbiol Immunol Infect 2013;46:53-58.
59.
Sackesen C, Sekerel BE, Orhan F, Kocabas CN, Tuncer A, Adalioglu G: The etiology of different forms of urticaria in childhood. Pediatr Dermatol 2004;21:102-108.
60.
Marrouche N, Grattan C: Childhood urticaria. Curr Opin Allergy Clin Immunol 2012;12:485-490.
61.
Cianferoni A, Novembre E, Pucci N, Lombardi E, Bernardini R, Vierucci A: Anaphylaxis: a 7-year follow-up survey of 46 children. Ann Allergy Asthma Immunol 2004;92:464-468.
62.
Novembre E, Cianferoni A, Bernardini R, Mugnaini L, Caffarelli C, Cavagni G, et al: Anaphylaxis in children: clinical and allergologic features. Pediatrics 1998;101:E8.
63.
Schneider G, Kachroo S, Jones N, Crean S, Rotella P, Avetisyan R, et al: A systematic review of validated methods for identifying anaphylaxis, including anaphylactic shock and angioneurotic edema, using administrative and claims data. Pharmacoepidemiol Drug Saf 2012;21(suppl 1):240-247.
64.
Sampson HA, Aceves S, Bock SA, James J, Jones S, Lang D, et al: Food allergy: a practice parameter update - 2014. J Allergy Clin Immunol 2014;134:1016-1025.e43.
65.
Bisgaard H, Bønnelykke K: Long-term studies of the natural history of asthma in childhood. J Allergy Clin Immunol 2010;126:187-197; quiz 198-199.
66.
Raedler D, Schaub B: Immune mechanisms and development of childhood asthma. Lancet Respir Med 2014;2:647-656.
67.
Sittka A, Vera J, Lai X, Schmeck BT: Asthma phenotyping, therapy, and prevention: what can we learn from systems biology? Pediatr Res 2013;73:543-552.
68.
Chung KF, Adcock IM: How variability in clinical phenotypes should guide research into disease mechanisms in asthma. Ann Am Thorac Soc 2013;10(suppl):S109-S117.
69.
Anderson GP: Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008;372:1107-1119.
70.
Lötvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, et al: Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011;127:355-360.
71.
Papadopoulos NG, Agache I, Bavbek S, Bilo BM, Braido F, Cardona V, et al: Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy 2012;2:21.
72.
Prosperi MC, Marinho S, Simpson A, Custovic A, Buchan IE: Predicting phenotypes of asthma and eczema with machine learning. BMC Med Genomics 2014;7(suppl 1):S7.
73.
Corren J: Asthma phenotypes and endotypes: an evolving paradigm for classification. Discov Med 2013;15:243-249.
74.
Mercer MJ, van der Linde GP, Joubert G: Rhinitis (allergic and nonallergic) in an atopic pediatric referral population in the grasslands of inland South Africa. Ann Allergy Asthma Immunol 2002;89:503-512.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.